[2-(-2-)-һ]-һ Ӣ ethyl 2-[2-(1,3-benzothiazol-2-ylsulfonylamino)ethylamino]acetate ܶ 1.365g/cm3 c 510.72?C at 760 mmHg ʽ C13H17N3O4S2 343.42200 Wc 262.674?C
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0109210 | 100mg |
1
|
ԃr |
Q-0109210 | 250mg |
1
|
ԃr |
Q-0109210 | 500mg |
1
|
ԃr |
Q-0109210 | 1g |
1
|
ԃr |
Q-0109210 | 5g |
1
|
ԃr |

[2-(-2-)-һ]-һ
Ӣ ethyl 2-[2-(1,3-benzothiazol-2-ylsulfonylamino)ethylamino]acetate
ܶ 1.365g/cm3
c 510.72ºC at 760 mmHg
ʽ C13H17N3O4S2
343.42200
Wc 262.674ºC
|(zh) 343.06600
PSA 134.01000
LogP 2.58990
1.599
P(gun)a(chn)Ʒ
(S)-2--3-((S)-2--3-)}} CAS:2628280-48-6
(R)-ʰ嶡}} CAS:256478-95-2
3,4--2-(()) CAS:2136287-65-3
N-(5,6-һ-2,3--1H--2-)-2,2,2- CAS:601487-87-0
N-̪-DL-Ȱ CAS:3343-28-0
4--3--2- CAS:170621-86-0
ʲ@ CAS:53956-04-1
B(ti)w/ĩ/Һ
a(chn)أ
rg1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹã
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
2,4,6-ȱ}} Ӣ (2,4,6-TRICHLOROPHENYL)HYDRAZINE HYDROCHLORIDE CAS̖ 2724-66-5
-
(1S,2S)-(+)-2-h(hun) Ӣ (1S,2S)-2-METHOXYCYCLOHEXANOL CAS̖ 134108-92-2